Xencor | XNCR - Market Capitalization


Xencor reported $1.46B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Xencor USD 1.19B 301M Jun/2026